I am relatively new to IHL and appreciate the discussions and videos posted here and have been following updates to the new website and name change. Really interested in how positioning as Biotech as opposed to just selling cannabis oil products.
But one thing I can't quite follow is the original Phase2a Sleep Apnoea trial with Austin Hospital.
Did this ever happen or did it stall and not receive HREC approval?
Was a reason given as to the seemingly lack of follow up? What will be different this time?
As according IHL ASX Release Date: 09/07/20 09:07Summary: Clinical Update on IHL-42X for Obstructive Sleep Apnoea.
Submission for new Alfred Phase2b was to be between 27th July and 5th August.
Do we know how long expected timeframe is for receiving HREC approval for this?
Are we expecting any reason why it would not gain approval?
Details on IHL clinical trials, page-7
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)